Historical shareholding details of iShares Biotechnology ETF holdings in Revance Therapeutics Inc (RVNC)

Monthly changes of iShares Biotechnology ETF shareholding in Revance Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Ishares Biotechnology Etf 602,477 0.58%
Jan 29, 2025 Ishares Biotechnology Etf 602,477 0.58%
Dec 31, 2024 Ishares Biotechnology Etf 619,065 0.59%
Dec 30, 2024 Ishares Biotechnology Etf 623,531 0.60%
Nov 30, 2024 Ishares Biotechnology Etf 642,777 0.62%
Nov 27, 2024 Ishares Biotechnology Etf 648,708 0.62%
Oct 31, 2024 Ishares Biotechnology Etf 661,888 0.63%
Oct 30, 2024 Ishares Biotechnology Etf 665,842 0.64%
Oct 29, 2024 Ishares Biotechnology Etf 665,842 0.64%
Sep 30, 2024 Ishares Biotechnology Etf 686,271 0.66%
Sep 27, 2024 Ishares Biotechnology Etf 684,953 0.66%
Sep 25, 2024 Ishares Biotechnology Etf 690,225 0.66%
Aug 30, 2024 Ishares Biotechnology Etf 699,322 0.67%
Aug 29, 2024 Ishares Biotechnology Etf 699,322 0.67%
Aug 28, 2024 Ishares Biotechnology Etf 694,042 0.67%
Jul 31, 2024 Ishares Biotechnology Etf 706,582 0.67%
Jul 29, 2024 Ishares Biotechnology Etf 710,542 0.68%
Jun 28, 2024 Ishares Biotechnology Etf 709,222 0.68%
Jun 13, 2024 Ishares Biotechnology Etf 692,855 0.66%
May 29, 2024 Ishares Biotechnology Etf 675,683 0.65%
Apr 30, 2024 Ishares Biotechnology Etf 699,215 0.67%
Apr 26, 2024 Ishares Biotechnology Etf 703,031 0.67%
Mar 27, 2024 Ishares Biotechnology Etf 602,863 0.58%
Feb 29, 2024 Ishares Biotechnology Etf 610,138 0.69%
Feb 28, 2024 Ishares Biotechnology Etf 612,883 0.70%
Jan 29, 2024 Ishares Biotechnology Etf 591,722 0.67%
Dec 27, 2023 Ishares Biotechnology Etf 586,362 0.67%
Nov 29, 2023 Ishares Biotechnology Etf 565,517 0.64%
Oct 27, 2023 Ishares Biotechnology Etf 589,142 0.67%
Sep 27, 2023 Ishares Biotechnology Etf 602,267 0.68%
Aug 29, 2023 Ishares Biotechnology Etf 560,633 0.64%
Jul 28, 2023 Ishares Biotechnology Etf 562,570 0.67%
Jun 21, 2023 Ishares Biotechnology Etf 568,562 0.68%
May 30, 2023 Ishares Biotechnology Etf 565,237 0.67%

View all ownership details of Revance Therapeutics Inc